These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1271248)

  • 1. Bioavailability assessment under quasi- and nonsteady-state conditions II: study designs.
    Yeh KC; Kwan KC
    J Pharm Sci; 1976 Apr; 65(4):512-7. PubMed ID: 1271248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability assessment under quasi- and nonsteady-state conditions. I: theoretical considerations.
    Kwan KC; Bondi JV; Yeh KC
    J Pharm Sci; 1975 Oct; 64(10):1639-42. PubMed ID: 1185529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability assessment under quasi- and nonsteady-state conditions III: Application.
    Bondi JV; Hucker HB; Yeh KC; Kwan KC
    J Pharm Sci; 1976 Nov; 65(11):1657-65. PubMed ID: 1036500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
    Cabana BE
    Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological availability].
    Weber E; Gundert-Remy U
    Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid methods for bioavailability determination utilizing urinary excretion data.
    Niebergall PJ; Sugita ET; Schnaare RL
    J Pharm Sci; 1975 Oct; 64(10):1721-2. PubMed ID: 1185547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
    Lalka D; du Souich P; McLean AJ; Gibaldi M
    J Pharm Sci; 1978 Apr; 67(4):591-2. PubMed ID: 641784
    [No Abstract]   [Full Text] [Related]  

  • 12. Circuit for simulation of multiple-dosing kinetics.
    Kirsten EB; Ross SM
    J Pharm Sci; 1972 Sep; 61(9):1468-70. PubMed ID: 5068954
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetic models].
    Dahl S
    Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
    [No Abstract]   [Full Text] [Related]  

  • 15. The general problem of drug bioavailability and its assessment in man.
    Smith RN
    Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosage, compliance and bioavailability in perspective.
    Biron P
    Can Med Assoc J; 1976 Jul; 115(2):102-3. PubMed ID: 1277066
    [No Abstract]   [Full Text] [Related]  

  • 17. Theory of the mean absorption time, an adjunct to conventional bioavailability studies.
    Cutler DJ
    J Pharm Pharmacol; 1978 Aug; 30(8):476-8. PubMed ID: 28392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioavailability and biopharmaceutics].
    Colombo BM; Colombo MM; De Fusco R
    Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel method for bioavailability assessment.
    Kwan KC; Till AE
    J Pharm Sci; 1973 Sep; 62(9):1494-7. PubMed ID: 4743100
    [No Abstract]   [Full Text] [Related]  

  • 20. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.
    Smolen VF
    J Pharmacokinet Biopharm; 1976 Aug; 4(4):337-53. PubMed ID: 978396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.